slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 58,861-58,890
Pages 2,605
Rows per page 30
Component
58,861-58,890 of 78,138
11
The slide includes a table-like summary for FY'20 and FY'21 growth rates in the top left corner.Broadridge Financial Solutions | Results Presentation Deck | 27 slides · Broadridge
Conference presentation Investor relations Beat · Financials1 hit
12
The chart uses a waterfall bridge to decompose the 16% growth into organic growth (closed sales, client losses, internal growth) and acquisitions.Broadridge Financial Solutions | Results Presentation Deck | 27 slides · Broadridge
Conference presentation Investor relations Beat · Financials1 hit
14
The chart shows a bridge-like comparison between GAAP and Adjusted margins, with bps improvements highlighted for historical years.Broadridge Financial Solutions | Results Presentation Deck | 27 slides · Broadridge
Conference presentation Investor relations 1 hit
15
The chart uses a stacked bar for FY'22 guidance to show the range of $240-$280M.Broadridge Financial Solutions | Results Presentation Deck | 27 slides · Broadridge
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
07
Broadridge Financial Solutions | Results Presentation Deck | 41 slidesBroadridge Financial Solutions | Results Presentation Deck | 41 slides · Broadridge
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit
08
Broadridge Financial Solutions | Results Presentation Deck | 41 slidesBroadridge Financial Solutions | Results Presentation Deck | 41 slides · Broadridge
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit
13
The chart tracks two primary metrics (Equity and MF/ETF) with a secondary metric (ITG) presented as a table row below the x-axis.Broadridge Financial Solutions | Results Presentation Deck | 41 slides · Broadridge
Conference presentation Investor relations Beat · Key Messages1 hit
20
The slide uses a combination of icons to represent the front, middle, and back office, connected by the Broadridge Wealth Platform, alongside a bar chart showing annual growth percentages.Broadridge Financial Solutions | Results Presentation Deck | 41 slides · Broadridge
Conference presentation Investor relations Loop · Maturity Curve1 hit
24
The slide contrasts Non-GAAP Adjusted Operating Income Margin with GAAP Operating Income Margin.Broadridge Financial Solutions | Results Presentation Deck | 41 slides · Broadridge
Conference presentation Investor relations 1 hit
11
The chart displays both absolute hours (in millions) and year-over-year growth percentages.BuzzFeed | Investor Presentation Deck | 29 slides · BuzzFeed
Pitch deck Investor relations Beat · Business Model1 hit
15
Includes a footnote regarding the inclusion of HuffPost and Complex acquisitions in 2021A figures.BuzzFeed | Investor Presentation Deck | 29 slides · BuzzFeed
Pitch deck Investor relations Beat · Business Model1 hit
16
The chart illustrates a transition from negative to positive EBITDA.BuzzFeed | Investor Presentation Deck | 29 slides · BuzzFeed
Pitch deck Investor relations Beat · Solution1 hit
19
The slide uses a process-flow layout to explain the 'Tasty' growth engine.BuzzFeed | Investor Presentation Deck | 29 slides · BuzzFeed
Pitch deck Investor relations Beat · Solution1 hit
05
The slide uses a mix of qualitative bullet points and quantitative metrics to establish the problem space.Cano Health | Investor Presentation Deck | 21 slides · Cano Health
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The chart uses a stacked bar format to compare 2021 actuals with 2026 projections, emphasizing the CAGR of the Medicare Advantage segment.Cano Health | Investor Presentation Deck | 21 slides · Cano Health
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
10
The slide highlights the dual-engine growth strategy of organic expansion and M&A.Cano Health | Investor Presentation Deck | 21 slides · Cano Health
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
11
Includes HEDIS quality score and NCQA certification metrics at the bottom.Cano Health | Investor Presentation Deck | 21 slides · Cano Health
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
The chart shows membership growth from Q1'21 to Q1'22, with a significant jump in Q1'22. The table below the chart shows the DCE percentage of total membership.Cano Health | Results Presentation Deck | 18 slides · Cano Health
Conference presentation Investor relations Beat · Evidence1 hit
07
The slide highlights the dual-engine growth strategy of organic expansion and acquisitions.Cano Health | Results Presentation Deck | 18 slides · Cano Health
Conference presentation Investor relations Beat · Evidence1 hit
09
The chart shows FDA approvals by therapeutic area, with a callout box emphasizing that 90% of novel drug approvals were achieved by the company's customers.Certara | Investor Presentation Deck | 30 slides · Certara
Pitch deck Investor relations 1 hit
10
The slide uses a value-chain style layout to show how software and services span from discovery to post-approval.Certara | Investor Presentation Deck | 30 slides · Certara
Pitch deck Investor relations 1 hit
19
The slide uses a dual-track timeline (Regulatory vs Product) combined with an acquisition history.Certara | Investor Presentation Deck | 30 slides · Certara
Pitch deck Investor relations 1 hit
11
The chart uses a standard oncology waterfall plot format to visualize tumor shrinkage.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
12
Standard clinical trial swimmer plot showing treatment duration, response (PR/SD), progression (PD), death, and ongoing status.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
10
Data sourced from Valle J et al. N Engl J Med 2010;362:1273-1281.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
13
Clinical trial data presented at ASCO GI22.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
14
Clinical trial data presented at ASCO GI 2022.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
22
The slide includes a 'Number at risk' table below the chart, which is standard for clinical trial survival analysis.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
27
The plot displays individual patient responses categorized by cancer type (Gastric, CRC, Cholangio, Pancreatic, Other).Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
32
Standard oncology waterfall plot showing individual patient response to treatment.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit